Castle Biosciences CSTL Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Castle Biosciences in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Castle Biosciences's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Castle Biosciences's operating income?
- Castle Biosciences (CSTL) reported operating income of -$18.41M in Q1 2026.
- How has Castle Biosciences's operating income changed year-over-year?
- Castle Biosciences's operating income increased by 34.1% year-over-year, from -$27.93M to -$18.41M.
- What is the long-term trend for Castle Biosciences's operating income?
- Over 4 years (2021 to 2025), Castle Biosciences's operating income has grown at a 1.7% compound annual growth rate (CAGR), from -$40.08M to -$42.81M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.